WO2025224732 - MENINGOCOCCAL HEXAVALENT COMBINATION VACCINE
National phase entry is expected:
Publication Number
WO/2025/224732
Publication Date
30.10.2025
International Application No.
PCT/IN2024/052447
International Filing Date
31.12.2024
Title **
[English]
MENINGOCOCCAL HEXAVALENT COMBINATION VACCINE
[French]
VACCIN COMBINÉ HEXAVALENT MÉNINGOCOCCIQUE
Applicants **
TECHINVENTION LIFECARE PRIVATE LIMITED
Inventors
AHMED, Syed S
SYED, Safia
KUMAR, Varnik
BHAGAWATI, Arnabjyoti
Priority Data
202421033292
26.04.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2184 | |
| EPO | Filing, Examination, Granting | 12123 | |
| Japan | Filing, Examination, Granting | 2204 | |
| South Korea | Filing, Examination, Granting | 2099 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
23,950
Contact Us
Abstract[English]
. The present invention further relates to the composition, use and process of preparation of hexavalent combination vaccine.[French]
. La présente invention concerne en outre la composition, l'utilisation et le procédé de préparation d'un vaccin combiné hexavalent.